Announcement: SEARCH FOR EDITOR-IN-CHIEF PEDIATRIC RESEARCH

M. Grumbach
DOI: https://doi.org/10.1203/00006450-198711000-00004
IF: 3.953
1987-11-01
Pediatric Research
Abstract:JC 1979 Reye-like syndrome associated with valproic acid therapy. J Pediatr 95:142-144 3. Sugimoto T. Yasuhara A. Matsumura T. Hara K. Sakane Y. Taniuchi K 1982 Hyperglycincmia and hyperammonemia following administration of valproate sodium. I n : Akimoto H. Kazamatsuri H. Seino M. Ward A (eds) Advances In Epileptology: Xlllth Epilepsy International Symposium. Raven Press, New York, pp 297-300 4. Ohtani Y. Endo F. Matsuda 1 1982 Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 101 :782-785 5. Sugimoto T, Nishida N. Yasuhara A. Ono A, Sakane Y. Matsumura T 1983 Reye-like syndrome associated with valproic acid. Brain Dev 5:334-337 6. Sugimoto T. Nishida N. Woo M. Takeuchi T. Yasuhara A. Kobayashi Y. Sakane Y 1986 Serum and urinary carnitine and organic acids In Reye syndrome and Reye-l~ke syndrome. Brain Dev 8:257-261 7. McGarry JD. Foster DW 1976 An ~mproved and simplified radioisotopic assay for the determination of frec and esterified carnitine. J Lipid Res 17:27728 1 8. Borum PR. York CM, Bennett SG 1985 Carnitine concentration of red blood cells. Am J Clin Nutr 41:653-656 9. Lowry OH, Resebrough NJ, Farr AL. Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275 10. Bonsnes RW. Taussky HH 1945 On the colorimetric determination of creatinine by the Jaffe reaction. J Biol Chem 158:58 1-59 1 I 1. Salway JG 1969 The simultaneous determination of acetoacetate and glucose in capillary blood. Clin Chem Acta 25:109-1 16 12. Glasgow AM. Chase HP 1975 Production of the features of Reye's syndrome in rats with 4-pentenoic acid. Pediatr Res 9: 133138 13. Mortcnsen PB. Gregersen N. Kolvraa S. Christensen E 1980 The occurrence of C6-CIO-dicarboxylic acids in urine from patients and rats treatcd with dipropylacetate. Biochem Med 24: 15316 1 14. Coude FX, Grimber A. Pelet A. Benoit Y 1983 Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocyte. Biochem Biophys Res Commun 1 15:730-736 15. Stumpf DA. Parker WD. Angelini C 1985 Carnitinc deficiency. organic acidemias. and Reye's syndrome. Neurology 35: 104 1 1045 16. Engel AG, Rebouche CJ. Wilson DM. Glasgow AM, Romche CA. Cruse RP 1981 Primary systemic carnitine deficiency. 11. Renal handling of carnitine. Neurology 3 1 :8 19-825 17. Matsuda I. Ohtani Y. Ninomiya N 1986 Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy. J Pediatr 109:131-143 18. Frilz IB. Marquis NR 1965 The role of acylcarnitine esters and carnitine palmityl transferase in the transport of fatty acyl groups across mitochondria1 membranes. Proc Natl Acad Sci USA 54:1226-1233 19. Roe CR, Bohan TP 1982 1:Carnitine therapy in propionic acidacmia. Lancet 1:1411-1412 20. Roe CR. Millington DS. Maltby DA. Bohan TP. Hoppel CL 1984 I.-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest 73: 17581788 21. Scccombe DW. Snyder F. Parsons HG 1982 I.-Carnitine for methylmalonic aciduria. Lancet 2: 1401 22. O'Connor J-E. Costell M. Grisolia S 1984 Protective effect of I.-carnitine on hyperammonemia. FEBS Lett 166:331-334 23. Brooks DE. Mclntosh 1975 Turnover of carnitine by rat tissues. Biochcm J 148:439-445 24. Ater SB, Swinyard EA. Tolman KG. Madsen JA, Matsuo F 1984 Effects of SKF525A. phenobarbital. fasting, and carnitine in the anticonvulsant activity and neurotoxicity of valproate in mice. Epilepsia 25:599-604
What problem does this paper attempt to address?